Laboratory Diagnosis of HIV Infection

Rapid HIV Antibody Tests Licensed in US, 2009

October 2009

There are currently 6 rapid HIV antibody tests that are licensed in the United States for screening of HIV infection. Those listed with an asterisk - there are 5 of these 6 - are also CLIA waived for point-of-care testing. Of note, many of these are available and FDA approved for testing saliva, plasma, serum, as well as whole blood, and they utilize a variety of chemistry methods, especially lateral flow immunochromatography or a flow-through membrane immunoconcentration.

< Previous Slide

Rapid HIV Antibody

Next Slide >

 

Jump to section:

• Introduction
• HIV Markers During Early Infection
• Assay-Defined HIV Detection Windows and Infection Periods
• Serologic Tests for HIV Infection in US
• Principle of Future Combined HIV Antigen-Antibody ELISAs
• Virology Tests for HIV Infection
• HIV Serologic Screening Algorithm
• HIV Rapid Serology Follow-up Algorithm
• Indeterminate HIV-1 Antibody Western Blot Results
• Rapid HIV Antibody Tests Licensed in US, 2009
• Predictive Value: Single Screening Test
• Rapid HIV Antibody Tests: Clinical Applications
• Follow-Up Testing of Reactive Rapid HIV-1 Antibody Tests Results
• Diagnostic HIV Testing in Infants
• Diagnostic HIV Testing in Infants
• Awareness of Serostatus Among People with HIV and Estimates of Transmission in US
• Reasons for Testing: Late vs. Early Testers
• 2006 US CDC Recommendations: Adults and Adolescents
• 2006 US CDC Recommendations: Adults and Adolescents
• 2006 US CDC Recommendations: Pregnant Women
• 2006 US CDC Recommendations: Pregnant Women
• Summary
• Questions?
• Disclosure